Daily non-political popular news in brief.

Socioeconomic position associated with effectiveness of HIV drugs

Socioeconomic position is a determinant of antiretroviral treatment effectiveness during initial therapy for HIV-1 infection. The effect was found even among subjects with high rates of drug adherence, according to a study published in the Aug. 1 issue of the Journal of Psychosomatic Research.

Read more »

Keywords: socioeconomic, position, associated, effectiveness, hiv, drugs, drug

« Previous | Next »

Similar news on "Socioeconomic position associated with effectiveness of HIV drugs":

1. Hepatitis B drug creates HIV resistance
   07-14-2007 · Science News Online
   A hepatitis B drug spurs resistance to HIV drugs in people infected with both diseases.
   Similar news · Read more »
   
2. HIV drug resistance risk in mothers reduced by combination of common drugs
   11-09-2007 · EurekAlert!
   Adding a single dose of two common anti-HIV drugs can prevent HIV-positive pregnant women from developing resistance to an entire class of drugs, potentially improving future treatment options.Providing tenofovir and emtricitabine with nevirapine during labor greatly reduces the extent of resistance to non-nucleoside reverse transcriptate inhibitors, such as nevirapine, which HIV-positive women take to lower the risk of mother-to-child transmission during childbirth.
   Similar news · Read more »
   
3. Antiretroviral drugs may protect against sexual transmission of HIV
   02-04-2008 · EurekAlert!
   A macaque study supports drug combinations to protect against infection with HIV.
   Similar news · Read more »
   
4. Bioabsorbable stent shows excellent performance
   03-24-2007 · EurekAlert!
   The use of slow-release drugs in stents (drug-eluting stents) has dramatically reduced restenosis rates after percutaneous coronary intervention. However, these permanent metal devices may impair coronary imaging, predispose patients to late stent thrombosis, prevent positive remodeling and hinder revascularization. A study presented today at the American College of Cardiology's Innovation in Intervention: i2Summit assesses the safety and performance of a bioabsorbable stent that, if effective, could eliminate several of the problems associated with metallic stents.
   Similar news · Read more »
   
5. Drug's potential adverse side effect explained
   09-06-2007 · EurekAlert!
   Drugs that are agonists of the receptor PPAR-gamma are used to treat individuals with diabetes. However, it has been suggested that their use is associated with a slightly increased risk of heart failure. A potential explanation for this adverse effect that is observed in a minority of patients is outlined in a new study in the Journal of Clinical Investigation.
   Similar news · Read more »
   
6. New study looks at long-term drug costs for treating AIDS in Brazil
   11-12-2007 · EurekAlert!
   AIDS continues to be a staggering global public health problem. However, little is known about the long-term costs associated with providing drugs to AIDS patients in developing countries. To study those long-term cost trends, researchers from the Harvard School of Public Health have performed the first detailed analysis of AIDS drug cost trends in Brazil.
   Similar news · Read more »
   
7. Blocking cancer-causing gene improves radiation effectiveness, Jefferson researchers find
   11-08-2006 · EurekAlert!
   Inhibiting a particular cancer-causing gene can enhance the cell-killing effects of radiation, a team of radiation oncologists and cancer biologists has found. Using a combination of zebrafish and antisense technology, they've shown that the drug flavopiridol works by blocking the activity of a gene, cyclin D1, which is overexpressed in about half of all breast cancers. Similar techniques in the future, the scientists say, may enable researchers to better gauge the effects of drugs.
   Similar news · Read more »
   
8. Experts urge strongest isolation for new drug-resistant tuberculosis cases appearing in South Africa
   01-22-2007 · EurekAlert!
   Medical ethics and other experts say tough isolation measures, involuntary if need be, are justified to contain a very deadly, highly-contagious and drug-resistant mutant strains of tuberculosis and to prevent "a potentially explosive international health crisis" brewing most dangerously at the epicenter of South Africa's HIV/AIDS epidemic. The new TB variations now defeat many of the world's existing drugs and pose "extreme risk."
   Similar news · Read more »
   
9. Drugs users are increasingly more cautious with needles
   05-14-2007 · EurekAlert!
   Even though HIV can be well treated these days, drug users are still more cautious about using needles than they used to be. That is the conclusion of Colette Smit following her study into 25 years of HIV in the Netherlands.
   Similar news · Read more »
   
10. Enzyme structure reveals new drug targets for cancer and other diseases
    02-14-2008 · EurekAlert!
    Researchers now have a clearer understanding of how a key protein controls gene activity and how mutations in the protein may cause disease. The work could provide new avenues to design drugs aimed at cancer, diabetes, HIV, and heart disease.
    Similar news · Read more »